JPMORGAN CHASE & CO - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 206 filers reported holding BEAM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,934,447
-29.5%
662,555
-6.4%
0.00%0.0%
Q2 2023$22,596,222
+2.2%
707,680
-2.0%
0.00%
-33.3%
Q1 2023$22,111,310
+76156.4%
722,135
-2.6%
0.00%
-25.0%
Q4 2022$28,996
-99.9%
741,415
-1.8%
0.00%
-20.0%
Q3 2022$35,975,000
+25.8%
755,156
+2.2%
0.01%
+25.0%
Q2 2022$28,600,000
-32.8%
738,860
-0.5%
0.00%
-20.0%
Q1 2022$42,555,000
-27.2%
742,669
+1.3%
0.01%
-28.6%
Q4 2021$58,421,000
+7.2%
733,094
+17.0%
0.01%0.0%
Q3 2021$54,514,000
-19.4%
626,512
+19.2%
0.01%
-12.5%
Q2 2021$67,668,000
+138.5%
525,740
+48.3%
0.01%
+100.0%
Q1 2021$28,372,000
+48.2%
354,488
+51.2%
0.00%
+33.3%
Q4 2020$19,141,000
+343.7%
234,458
+34.3%
0.00%
+200.0%
Q3 2020$4,314,000
+276.4%
174,523
+326.4%
0.00%
Q2 2020$1,146,000
+58.5%
40,929
+1.8%
0.00%
Q1 2020$723,00040,1860.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$304,095,00029.88%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,391$28,881,00022.15%
HSG Holding Ltd 796,089$102,465,0007.14%
DC Investments Management, LLC 21,010$2,704,0006.36%
PATHWAY CAPITAL MANAGEMENT, LP 112,197$14,441,0005.74%
Redmile Group, LLC 2,052,506$264,178,0003.91%
Casdin Capital, LLC 818,820$105,390,0002.68%
Darwin Global Management, Ltd. 126,985$16,344,0002.64%
Evolutionary Tree Capital Management, LLC 44,032$5,667,0002.61%
HHLR ADVISORS, LTD. 1,845,753$237,567,0002.44%
View complete list of BEAM THERAPEUTICS INC shareholders